Meet Priti Hegde, Ph.D., talking about the value of genomic profiling in lung cancer patients.
Turning cancer into a chronic disease
On today's episode we're talking about precision medicine in lung cancer. Meet Priti Hegde, Ph.D., Chief Scientific Officer of Foundation Medicine, Inc., a life science company that offers a portfolio of comprehensive genomic profiling products that help physicians make more informed care decisions. She is passionate about innovation in cancer research and translating innovations to precision medicine tools to advance care for patients. Dr. Hegde explains the current science of genomic testing and what the future holds. She also talks about building long term relationships with patients and helping young women scientists get a seat at the right table.
Chief Scientific Officer of Foundation Medicine, Inc.
